Global Gastrointestinal Drugs Market Insights, Forecast to 2029
상품코드:1398343
리서치사:QYResearch
발행일:2023년 12월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 위장약 시장 규모는 2023년 409억 2,260만 달러에서 예측 기간 동안 4.67%의 CAGR을 기록하며 2029년에는 538억 2,000만 달러 규모로 성장할 것으로 예상됩니다.
북미 시장은 2023년 125억 7,500만 달러에서 4.35%의 CAGR로 2029년에는 162억 3,800만 달러에 달할 것으로 예상됩니다. 중국 시장은 2023년 59억 8,800만 달러에서 6.36%의 CAGR로 2029년 86억 7,000만 달러에 달할 것으로 예상됩니다. 또한, 유럽 시장은 2023년 87억 1,200만 달러에서 4.61%의 CAGR로 2029년에는 114억 2,000만 달러에 달할 것으로 예상됩니다.
세계 위장약 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 유형별·용도별 분석, 지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 조사 내용
위장약 제품 : 서론
유형별 시장
성장률 : 2018 vs 2022 vs 2029
처방약
OTC 의약품
용도별 시장
성장률 : 2018 vs 2022 vs 2029
염증성 장질환
IBS 질환
소화성 궤양
역류성 식도염
가정·제한
조사 목적
조사 기간
제2장 주요 요약
세계의 매출 추정과 예측
매출 추정과 예측·점유율 : 지역별
세계의 판매량 추정과 예측
판매량 추정과 예측·점유율 : 지역별
북미
유럽
중국
아시아(중국 제외)
중동, 아프리카 및 라틴아메리카
제3장 경쟁 상황 : 제조업체별
판매량 추정·점유율·주요 기업 : 제조업체별
매출 추정·점유율·주요 기업 : 제조업체별
세계의 주요 기업 : 업계 순위
판매 가격 : 제조업체별
경쟁 상황 분석
세계의 주요 제조업체 : 제조 거점 분포·본사
세계의 주요 제조업체 : 설립일
M&A·확장 계획
제4장 시장 규모 : 유형별
판매량 추정과 예측·시장 점유율
매출 추정과 예측·시장 점유율
가격 추정과 예측
제5장 시장 규모 : 용도별
판매량 추정과 예측·시장 점유율
매출 추정과 예측·시장 점유율
가격 추정과 예측
제6장 북미
제7장 유럽
제8장 중국
제9장 아시아(중국 제외)
제10장 중동, 아프리카 및 라틴아메리카
제11장 기업 개요
Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Huadong Pharmaceutical
Bausch Health
제12장 산업 체인과 판매 채널 분석
산업 체인 분석
주요 원재료
제조 모드와 프로세스
판매·마케팅
고객
제13장 위장약 : 시장 역학
산업 동향
시장 성장 촉진요인
시장 과제
시장 성장 억제요인
제14장 세계의 위장약 시장 : 주요 조사 결과
제15장 부록
ksm
영문 목차
영문목차
The global market for Gastrointestinal Drugs estimated at US$ 40922.6 million in the year 2023, is projected to reach a revised size of US$ 53820 million by 2029, growing at a CAGR of 4.67% during the forecast period 2023-2029.
The North America market for Gastrointestinal Drugs is estimated to increase from $ 12575 million in 2023 to reach $ 16238 million by 2029, at a CAGR of 4.35% during the forecast period of 2023 through 2029.
The China market for Gastrointestinal Drugs is estimated to increase from $ 5988 million in 2023 to reach $ 8670 million by 2029, at a CAGR of 6.36% during the forecast period of 2023 through 2029.
The Europe market for Gastrointestinal Drugs is estimated to increase from $ 8712 million in 2023 to reach $ 11420 million by 2029, at a CAGR of 4.61 % during the forecast period of 2023 through 2029.
The global key manufacturers of Gastrointestinal Drugs include: Takeda, Bausch Health, Abbvie, AstraZeneca, Teva, Bayer, Pfizer, Sun Pharma, etc. In 2022, the global top five players had a share approximately 40.67% in terms of revenue.
Report Includes:
This report presents an overview of global market for Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Bayer, Pfizer, GSK, Teva, Zeria, Perrigo, and Boehringer Ingelheim, etc.
By Company
Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Huadong Pharmaceutical
Bausch Health
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Inflammatory Bowel Disease
IBS Disease
Peptic Ulcer
GERD
Other
Segment by Region
North America
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
TABLE OF CONTENTS
1 STUDY COVERAGE
1.1 Gastrointestinal Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Inflammatory Bowel Disease
1.3.3 IBS Disease
1.3.4 Peptic Ulcer
1.3.5 GERD
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Gastrointestinal Drugs Revenue Estimates and Forecasts 2018-2029
2.2 Global Gastrointestinal Drugs Revenue by Region
2.2.1 Global Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gastrointestinal Drugs Revenue by Region (2018-2023)
2.2.3 Global Gastrointestinal Drugs Revenue by Region (2024-2029)
2.2.4 Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Gastrointestinal Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Gastrointestinal Drugs Sales by Region
2.4.1 Global Gastrointestinal Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gastrointestinal Drugs Sales by Region (2018-2023)
2.4.3 Global Sales Gastrointestinal Drugs by Region (2024-2029)
2.4.4 Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
2.5 North America
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURERS
3.1 Global Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top Largest Manufacturers of Gastrointestinal Drugs in 2022
3.2 Global Gastrointestinal Drugs Revenue by Manufacturers
3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top Companies by Gastrointestinal Drugs Revenue in 2022
3.3 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022
3.4 Global Gastrointestinal Drugs Sales Price by Manufacturers (2018-2023)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gastrointestinal Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gastrointestinal Drugs, Founded Date
3.8 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Gastrointestinal Drugs Sales by Type
4.1.1 Global Gastrointestinal Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Gastrointestinal Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gastrointestinal Drugs Revenue by Type
4.2.1 Global Gastrointestinal Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gastrointestinal Drugs Price by Type
4.3.1 Global Gastrointestinal Drugs Price by Type (2018-2023)
4.3.2 Global Gastrointestinal Drugs Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Gastrointestinal Drugs Sales by Application
5.1.1 Global Gastrointestinal Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Gastrointestinal Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gastrointestinal Drugs Revenue by Application
5.2.1 Global Gastrointestinal Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gastrointestinal Drugs Price by Application
5.3.1 Global Gastrointestinal Drugs Price by Application (2018-2023)
5.3.2 Global Gastrointestinal Drugs Price Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gastrointestinal Drugs Market Size by Type
6.1.1 North America Gastrointestinal Drugs Sales by Type (2018-2029)
6.1.2 North America Gastrointestinal Drugs Revenue by Type (2018-2029)
6.2 North America Gastrointestinal Drugs Market Size by Application
6.2.1 North America Gastrointestinal Drugs Sales by Application (2018-2029)
6.2.2 North America Gastrointestinal Drugs Revenue by Application (2018-2029)
6.3 North America Gastrointestinal Drugs Market Size by Country
6.3.1 North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 North America Gastrointestinal Drugs Revenue by Country (2018-2029)
6.3.3 North America Gastrointestinal Drugs Sales by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Gastrointestinal Drugs Market Size by Type
7.1.1 Europe Gastrointestinal Drugs Sales by Type (2018-2029)
7.1.2 Europe Gastrointestinal Drugs Revenue by Type (2018-2029)
7.2 Europe Gastrointestinal Drugs Market Size by Application
7.2.1 Europe Gastrointestinal Drugs Sales by Application (2018-2029)
7.2.2 Europe Gastrointestinal Drugs Revenue by Application (2018-2029)
7.3 Europe Gastrointestinal Drugs Market Size by Country
7.3.1 Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gastrointestinal Drugs Revenue by Country (2018-2029)
7.3.3 Europe Gastrointestinal Drugs Sales by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Gastrointestinal Drugs Market Size by Type
8.1.1 China Gastrointestinal Drugs Sales by Type (2018-2029)
8.1.2 China Gastrointestinal Drugs Revenue by Type (2018-2029)
8.2 China Gastrointestinal Drugs Market Size by Application
8.2.1 China Gastrointestinal Drugs Sales by Application (2018-2029)
8.2.2 China Gastrointestinal Drugs Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Gastrointestinal Drugs Market Size by Type
9.1.1 Asia Gastrointestinal Drugs Sales by Type (2018-2029)
9.1.2 Asia Gastrointestinal Drugs Revenue by Type (2018-2029)
9.2 Asia Gastrointestinal Drugs Market Size by Application
9.2.1 Asia Gastrointestinal Drugs Sales by Application (2018-2029)
9.2.2 Asia Gastrointestinal Drugs Revenue by Application (2018-2029)
9.3 Asia Gastrointestinal Drugs Market Size by Region
9.3.1 Asia Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gastrointestinal Drugs Revenue by Region (2018-2029)
9.3.3 Asia Gastrointestinal Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 Southeast Asia
9.3.7 India
9.3.8 Australia
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Country
10.3.1 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2029)
